Spleen Stiffness Predicts the Risk of Liver-related Complications in Patients With Compensated Advanced Chronic Liver Disease
Clinical Gastroenterology and Hepatology · 2025
DOI: 10.1016/j.cgh.2025.01.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Rui Gaspar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Centro Hospitalar de São João, Porto, Portugal. Electronic address: u011324@chsj.min-saude.pt. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Spleen, Hypertension, Portal, Liver Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND & AIMS: The development of portal hypertension (PH) is a key prognostic factor in patients with compensated advanced chronic liver disease (cACLD). The gold standard for assessing PH is the hepatic venous pressure gradient measurement. However, noninvasive tools have gained significant importance in recent years, mainly liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE). Spleen stiffness measurement (SSM) by VCTE using a dedicated 100-Hz module has emerged as a promising non-invasive diagnostic tool, although data on its prognostic value remain limited. This study aimed to evaluate the accuracy of SSM, as measured by transient elastography, in predicting the risk of liver decompensation. METHODS: A prospective study was conducted including patients with cACLD followed at a tertiary center from January 2020 to April 2024. All patients underwent liver and spleen VCTE (utilizing the 100-Hz module) performed by the same blinded operator. Patients were subsequently monitored at the same institution for the development of PH complications. RESULTS: The study included 242 patients with cACLD, with a mean age of 63.0 ± 10.5 years and who were 78.5% male. The most common etiology was alcoholic liver disease (62.0%). The median LSM value was 21.9 kPa (interquartile range [IQR], 15.0-34.0 kPa), and the median SSM value was 38.9 kPa (IQR, 28.0-58.0 kPa). The median follow-up period was 501.5 days (IQR, 343.0-725.3 days). During this time, 28 patients (11.6%) developed liver decompensations, with 20 requiring hospital admission. SSM demonstrated good predictive capacity for the risk of liver decompensation (area under the curve, 0.823; 95% confidence interval, 0.742-0.904). Alongside LSM, SSM was an effective predictor of liver decompensation, with a cutoff of 50.0 kPa indicating a significantly increased risk of hepatic decompensation. CONCLUSIONS: Noninvasive assessment using SSM may serve as an excellent tool for predicting the risk of liver-related complications and risk-stratifying patients with cACLD, thereby improving their management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Centro Hospitalar de São João, Porto, Portugal. Electronic address: u011324@chsj.min-saude.pt.
- Department of Gastroenterology and Hepatology, Centro Hospitalar de São João, Porto, Portugal.
- Mathematics Department, University of Aveiro, Aveiro, Portugal.
Zitieren
APA
Gaspar, R., Mota, J., Almeida, M. J., Silva, M., Lau, B., & Macedo, G. (2025). Spleen Stiffness Predicts the Risk of Liver-related Complications in Patients With Compensated Advanced Chronic Liver Disease. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2025.01.031
Vancouver
Gaspar R, Mota J, Almeida MJ, Silva M, Lau B, Macedo G. Spleen Stiffness Predicts the Risk of Liver-related Complications in Patients With Compensated Advanced Chronic Liver Disease. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2025.01.031
BibTeX
@article{Gaspar2025,
author = {Gaspar, Rui and Mota, Joana and Almeida, Maria João and Silva, Marco and Lau, Beatriz and Macedo, Guilherme},
title = {Spleen Stiffness Predicts the Risk of Liver-related Complications in Patients With Compensated Advanced Chronic Liver Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
doi = {10.1016/j.cgh.2025.01.031}
}
EUVIMED